A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer (Q35034712)

5 August 2017

A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer (English)

1 reference

5 August 2017

M Hauptmann

5

0 references

author name string

T J Molloy

1

1 reference

5 August 2017

L A Devriese

2

1 reference

5 August 2017

H H Helgason

3

1 reference

5 August 2017

A J Bosma

4

1 reference

5 August 2017

E E Voest

6

1 reference

5 August 2017

J H M Schellens

7

1 reference

5 August 2017

L J van't Veer

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

17 May 2011

1 reference

British Journal of Cancer

5 August 2017

1 reference

5 August 2017

104

1 reference

5 August 2017

12

1 reference

5 August 2017

1913-1919

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2011.164

5 August 2017

0 references

cites work

Epithelial-to-mesenchymal transitions and circulating tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Monitoring the decrease in breast cancer mortality in Europe

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

A gene-expression signature as a predictor of survival in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Detection and clinical importance of micrometastatic disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Statistical methods in diagnosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111197

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.164

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.164

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.164

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.164

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.164

External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.164

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

21 January 2018

1 reference

12 December 2020

Detection of circulating breast tumor cells by differential expression of marker genes

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up

1 reference

12 December 2020

Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay

1 reference

12 December 2020

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

1 reference

12 December 2020

Comparison of two methods for enumerating circulating tumor cells in carcinoma patients

1 reference

12 December 2020

Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden

1 reference

12 December 2020

HER2 as marker for the detection of circulating tumor cells

1 reference

12 December 2020

Medicine. Cancer's circulation problem

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2011.164

1 reference

5 August 2017

1 reference

5 August 2017

1 reference